MOBKL1A/MOBKL1B phosphorylation by MST1 and MST2 inhibits cell proliferation

Maria Praskova1, Fan Xia, Joseph Avruch

  • 1Diabetes Unit and Medical Services and Department of Molecular Biology, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.

Current Biology : CB
|March 11, 2008
PubMed
Abstract

Insights

Mammalian Ste20-related kinases MST1 and MST2 are activated during mitosis, phosphorylating MOBKL1A/MOBKL1B. This phosphorylation inhibits cell proliferation by regulating cell cycle progression.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • MST1 and MST2 are mammalian Ste20-related protein kinases homologous to Drosophila Hippo.
  • Their role in mammalian cell proliferation and regulation is not well understood.
  • Overexpression of MST1/MST2 is pro-apoptotic, but physiological regulation remains unclear.

Purpose of the Study:

  • To investigate the physiological regulation of MST1 and MST2 kinases.
  • To identify MST1/MST2 substrates involved in cell proliferation control.
  • To elucidate the role of MST1/MST2 in mammalian cell cycle regulation.

Main Methods:

  • Assessing MST1/MST2 kinase activity during mitosis and in response to stimuli (nocodazole, okadaic acid, H2O2).
  • Identifying and characterizing MST1/MST2 substrates using in vitro and in cell assays.
  • Utilizing non-phosphorylatable mutants to assess the functional impact of MOBKL1A/MOBKL1B phosphorylation.

Main Results:

  • MST1 and MST2 activity and abundance increase during mitosis.
  • MOBKL1A and MOBKL1B are identified as direct MST1/MST2 substrates, phosphorylated in mitosis and upon stimulation.
  • Phosphorylation of MOBKL1A/MOBKL1B by MST1/MST2 promotes binding to LATS1 and enables LATS1 activation.
  • Cells expressing non-phosphorylatable MOBKL1A/MOBKL1B exhibit accelerated proliferation.

Conclusions:

  • MST1 and MST2 are activated during mitosis and phosphorylate MOBKL1A/MOBKL1B.
  • Mitotic phosphorylation of MOBKL1A/MOBKL1B by MST1/MST2 is a key regulator of cell proliferation.
  • This regulatory mechanism impacts cell cycle progression at multiple points.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...